A new research marketplace for biotech startups has been launched by One Nucleus, the life science membership guardian of the Cambridge life...

The list of IT vendors and service providers that have yet to strike a deal with AstraZeneca ($AZN) in 2015 keeps getting shorter...

This story appeared in the San Diego Business Journal. Making a drug used to fall to Big Pharma, costing a billion dollars and requiring resources...

In the world of drug discovery, pharmaceutical companies face a very sobering statistic – more than 90% of the drugs that reach clinical testing...

I’ve been thinking a lot lately about how to optimize for ligand affinity. Of course, this is a central theme of all drug discovery projects. At...

Anyone who has taken a general laboratory class knows that the lab manual has multiple protocols that one follows in order to complete each week’s...

Drug discovery, ever a challenge, can be likened to a tall structure. The upper stories rely on the stability of the floors below it, and a solid...

Innovation is suddenly the word on everybody’s lips. Pfizer launched “Centers for Therapeutic Innovation”, Johnson and Johnson followed with their...

Sometimes, in tragic circumstances, a lesson can be learned and applied in unexpected ways. That appears to be the case with a rare disease that...

We have recently discussed here how crowdfunding – donations from the general public in support of a cause, idea, or invention – has caught the...